Thyroid-Hormone–Disrupting Chemicals: Evidence for Dose-Dependent Additivity or Synergism by Crofton, Kevin M. et al.
Thyroid-disrupting chemicals (TDCs) are
xenobiotics that alter the structure or function
of the thyroid gland, alter regulatory enzymes
associated with thyroid hormone (TH) home-
ostasis, or change circulating or tissue concen-
trations of THs. TDCs include a wide range of
chemical structures. Chemicals such as per-
chlorate inhibit the uptake of iodide into the
thyroid gland, with subsequent decrease in
iodine-based TH synthesis (Wolff 1998).
Other chemicals (e.g., thionamides, amitrole,
and ethylenethiourea) decrease TH synthesis
by inhibition of thyroid peroxidase (Capen
1997, 1998; Hill et al. 1998; Hurley 1998;
McClain 1995). Many classes of xenobiotics
alter TH levels by altering catabolic pathways.
Polyhalogenated aromatic hydrocarbons
(PHAHs) represent one such class of chemicals
that induce uridine diphosphoglucuronosyl
transferases (UGTs). UGTs glucuronidate
THs, and induction of these enzymes increases
the elimination of THs (Hill et al. 1998;
Hood and Klaassen 2000a; McClain et al.
1989; Oppenheimer et al. 1968).
A major uncertainty regarding the
endocrine-disrupting ability of environmental
xenobiotics is the potential for additive or syn-
ergistic (i.e., greater-than-additive) effects of
exposure to mixtures (Daston et al. 2003;
International Programme on Chemical Safety
2002). Solving the problem of predicting the
effects of chemical mixtures is a daunting task.
There are limited studies in the peer-reviewed
literature that examine mixtures of TDCs
(Desaulniers et al. 2003; Teuschler et al.
2002; Wade et al. 2002). Desaulniers et al.
(2003) found that use of 2,3,7,8-tetra-
chlorodibenzo-p-dioxin (TCDD) toxic equiv-
alents predicted the additive effects of a
mixture of coplanar polychlorinated biphenyls
(PCBs), polychlorinated dibenzo-p-dioxins,
and polychlorinated dibenzofurans on circu-
lating thyroxine (T4) concentrations in neo-
natal rats. Wade et al. (2002) subchronically
exposed adult male rats to a complex mixture
of 16 organochlorines, lead, and cadmium.
Effects on thyroid histopathology and hor-
mone concentrations were underpredicted
based on assumptions of additivity using pub-
lished health advisories [e.g., reference doses
(RfDs), acceptable daily intakes (ADIs)].
These previous efforts investigated the effects
of mixtures without concurrent experimental
characterization of the effects of the individual
chemicals. This type of approach is useful on a
case-by-case basis but does not help answer
global issues in the arena of mixtures risk
assessments (LeBlanc and Olmstead 2004).
Our present study tested the hypothesis
that a mixture of 18 PHAHs acts in a dose-
additive manner. The hypothesis was tested
using a flexible single-chemical-required
(FSCR) method of analysis (Gennings et al.
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Endocrine disruption from environmental contaminants has been linked to a broad spectrum of
adverse outcomes. One concern about endocrine-disrupting xenobiotics is the potential for additive
or synergistic (i.e., greater-than-additive) effects of mixtures. A short-term dosing model to examine
the effects of environmental mixtures on thyroid homeostasis has been developed. Prototypic
thyroid-disrupting chemicals (TDCs) such as dioxins, polychlorinated biphenyls (PCBs), and poly-
brominated diphenyl ethers have been shown to alter thyroid hormone homeostasis in this model
primarily by up-regulating hepatic catabolism of thyroid hormones via at least two mechanisms.
Our present effort tested the hypothesis that a mixture of TDCs will affect serum total thyroxine
(T4) concentrations in a dose-additive manner. Young female Long-Evans rats were dosed via gav-
age with 18 different polyyhalogenated aromatic hydrocarbons [2 dioxins, 4 dibenzofurans, and
12 PCBs, including dioxin-like and non-dioxin-like PCBs] for 4 consecutive days. Serum total T4
was measured via radioimmunoassay in samples collected 24 hr after the last dose. Extensive
dose–response functions (based on seven to nine doses per chemical) were determined for individ-
ual chemicals. A mixture was custom synthesized with the ratio of chemicals based on environmen-
tal concentrations. Serial dilutions of this mixture ranged from approximately background levels to
100-fold greater than background human daily intakes. Six serial dilutions of the mixture were
tested in the same 4-day assay. Doses of individual chemicals that were associated with a 30% TH
decrease from control (ED30), as well as predicted mixture outcomes were calculated using a ﬂexible
single-chemical-required method applicable to chemicals with differing dose thresholds and maxi-
mum-effect asymptotes. The single-chemical data were modeled without and with the mixture data
to determine, respectively, the expected mixture response (the additivity model) and the experimen-
tally observed mixture response (the empirical model). A likelihood-ratio test revealed statistically
significant departure from dose additivity. There was no deviation from additivity at the lowest
doses of the mixture, but there was a greater-than-additive effect at the three highest mixtures
doses. At high doses the additivity model underpredicted the empirical effects by 2- to 3-fold.
These are the ﬁrst results to suggest dose-dependent additivity and synergism in TDCs that may act
via different mechanisms in a complex mixture. The results imply that cumulative risk approaches
be considered when assessing the risk of exposure to chemical mixtures that contain TDCs.
Key words: additivity, cumulative risk, polyhalogenated aromatic hydrocarbons, synergism, thyroid
hormone disruptors. Environ Health Perspect 113:1549–1554 (2005). doi:10.1289/ehp.8195 avail-
able via http://dx.doi.org/ [Online 21 July 2005]2004). This model assumes that the effects of
the mixture will be predicted by the constraint
of Berenbaum’s definition of additivity
(Berenbaum 1985). In addition this model
allows the calculation of the predicted mixture
outcome for chemicals with differing dose
thresholds and maximum asymptotes
(Gennings et al. 2002, 2004). A short-term
oral exposure model (Craft et al. 2002) was
used to estimate the impact of 18 PHAHs,
both alone and as dilutions of an 18-chemical
mixture, on serum T4 concentrations. This
exposure paradigm allowed for an economic
approach to deriving extensive dose–response
information (seven to nine doses per chemical)
for 18 individual chemicals. Doses associated
with a 30% TH decrease from control (ED30
estimates) were calculated for each chemical,
rather than ED50 estimates because some
chemicals had asymptotic responses at a 50%
decrease. We then tested a mixture of these
18 PHAHs in which the chemical ratios were
based on a rough average of concentrations
found in breast milk, fish, and other food
sources of human exposure (Giesy et al. 1994;
Larsen et al. 1994; Patterson et al. 1994;
Schecter et al. 1994a, 1994b). Concentrations
of the individual chemicals in the undiluted
mixture were at least an order of magnitude
lower than those found to have significant
biologic activity (with the exception of
PCB-126, where there was an ~ 16% decrease
in T4 at the dose found in the highest concen-
tration of the mixture). Last, the exposures
ranged from approximately background
human body burdens to body burdens similar
to some highly exposed populations (DeVito
et al. 1995; Liem et al. 2000; Longnecker
et al. 2003; Lorber 2002). We used this
approach to decrease uncertainty in low-dose
extrapolation in mixture testing (Feron and
Groten 2002).
Materials and Methods
Chemicals. All individual PHAHs were
obtained from Accustandard Corporation
(New Haven, CT) or Radian Corporation
(Austin TX) at purities > 99%. Non-coplanar
PCBs were custom synthesized for 99.9%
purity. The following chemicals were tested:
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD);
1,2,3,7,8-pentachlorodibenzo-p-dioxin
(PCDD); 2,3,7,8-tetrachlorodibenzofuran
(TCDF); 1,2,3,7,8-pentachlorodibenzofuran
(1-PCDF); 2,3,4,7,8-pentachlorodibenzofuran
(4-PCDF); 1,2,3,4,6,7,8,9-octachlorodibenzo-
furan (OCDF); 2,4,4´-trichlorobiphenyl
(PCB-28); 2,2´,5,5´-tetrachlorobiphenyl
(PCB-52); 3,3´,4,4´-tetrachlorobiphenyl
(PCB-77); 2,2´,4,5,5´-pentachlorobiphenyl
(PCB-101); 2,3,3´,4,4´-pentachlorobiphenyl
(PCB-105); 2,3´,4,4´,5-pentachlorobiphenyl
(PCB-118); 3,3´,4,4´,5-pentachlorobiphenyl
(PCB-126); 2,2´,3,4,4´,5´-hexachlorobiphenyl
(PCB-138); 2,2´,4,4´,5,5´-hexachlorobiphenyl
(PCB-153); 2,3,3´,4,4´,5-hexachlorobiphenyl
(PCB-156); 3,3´,4,4´,5,5´-hexachlorobiphenyl
(PCB-169); and 2,2´,3,4,4´,5,5´-heptachloro-
biphenyl (PCB-180). The dose ranges and
number of dose groups are provided in
Table 1. The PHAH mixture was custom syn-
thesized by Cambridge Isotope Laboratories
(Andover, MA) and delivered to the U.S.
Environmental Protection Agency (EPA) in
corn oil at 3 times the highest tested concentra-
tion. Concentrations of individual chemicals in
the mixture (Table 2) were verified by chro-
matographic/mass spectrophotometric analyses
(Accustandard Corp., New Haven, CT ). The
concentrations used in our present study were
determined analytically and varied only slightly
from the target concentrations. The ratio of
chemicals in the mixture was based on the
ratios of PHAHs found in breast milk, fish,
and other sources of human exposure (Giesy
et al. 1994; Larsen et al. 1994; Patterson et al.
1994; Schecter et al. 1994a, 1994b). All dosing
solutions were prepared by dilution of the
stock solutions with corn oil (Sigma Chemical
Co., St. Louis, MO).
Animals and dosing. We obtained female
Long Evans rats (23 days of age) from Charles
River Laboratory (Raleigh, NC) and allowed
them to acclimate for a minimum of 4 days in
an animal facility approved by the Association
for Accreditation of Laboratory Animal Care
before being treated. Two animals were housed
per plastic cage (45 cm × 24 cm × 20 cm),
with heat-treated pine shaving bedding. They
were maintained at 21 ± 2°C with 50 ± 10%
humidity on a 12/12-hr light/dark cycle (lights
on 0600–1800 hr). Feed (Purina Rodent
Chow 5001, Barnes Supply Co., Durham,
NC) and tap water were provided ad libitum.
All animal procedures were approved by the
U.S. EPA Institutional Animal Care and Use
Committee.
We dosed rats by oral gavage for 4 consec-
utive days with each individual chemical to
establish dose–effect functions. This paradigm
was previously shown to result in dose-related
decreases in T4 concentrations after exposure
to PCB-126 and PCB-153 (Craft et al. 2002).
Dose ranges and numbers of dose groups are
shown in Table 1. We spaced doses at one-half
and one-third log units with the aim to have
two to three doses with no measurable
response, three to four doses closely spaced
around the no-effect level, and two to three
doses on the descending portion of the dose
response. We used two to three separate blocks
of animals (separate groups of animals ordered,
dosed, and sampled at different dates) to map
the dose response for each chemical. Blocks
were used to enable testing of large dose ranges.
Numbers of animals per group were not simi-
lar for each block and ranged from 4 at some
of the highest concentrations to 14 in some
low-dose and control groups. Control animals
(n = 8–14) were dosed with the vehicle
(1.0 mL/kg corn oil) only. The mixture study
was conducted with serial dilutions of the mix-
ture (n = 12/dose). We recorded body weights
daily and adjusted dosing volumes daily. Rats
were semirandomly assigned to treatment
groups by counterbalancing for body weights.
On the day following the last dose, animals
were randomly sacriﬁced by decapitation (no
anesthesia) between 0800 and 1000 hr. Trunk
blood was harvested and allowed to clot on ice
for 45–90 min. Serum was obtained by cen-
trifugation of clotted blood at 2,500 rpm at
4°C for 20 min and stored at –80°C until
analysis.
T4 assays. We measured serum total T4 by
standard radioimmunoassay assay kits
(Diagnostic Products Corporation, Los
Angeles, CA) and analyzed all samples in
duplicate. Intraassay and interassay coefﬁcients
of variance for all assays were below 10%.
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Table 1. Chemicals tested, dose ranges, and number
of doses, for individual chemicals.
Chemical Dose range (µg/kg/day) No. of dosesa
TCDD 0.0001–10 10
PCDD 0.003–10 10
TCDF 0.3–100 7
1-PCDF 0.03–100 7
4-PCDF 0.03–90 9
OCDF 0.1–300 8
PCB-28 100–90,000 9
PCB-52 100–90,000 9
PCB-77 100–30,000 8
PCB-101 50–30,000 9
PCB-105 90–90,000 8
PCB-118 10–10,000 9
PCB-126 0.001–100 10
PCB-138 100–90,000 9
PCB-153 100–90,000 9
PCB-156 10–10,000 8
PCB-169 1–1,000 8
PCB-180 100–90,000 8
aIncludes a control group.
Table 2. Chemical composition of the mixture.
Concentrationa Ratio Ratio
Chemical (µg/mL) (TCDD) (total mass)
TCDD 0.013 1.0 0.000007
PCDD 0.013 1.0 0.000007
TCDF 0.019 1.4 0.000010
1-PCDF 0.006 0.4 0.000003
4-PCDF 0.026 1.9 0.000013
OCDF 0.065 4.6 0.000032
PCB-28 78.600 5,605.3 0.039237
PCB-52 155.200 11,074.7 0.077523
PCB-77 2.000 141.1 0.000988
PCB-101 153.800 10,973.4 0.076814
PCB-105 76.700 5,468.9 0.038282
PCB-118 381.100 27,186.0 0.190302
PCB-126 0.610 43.1 0.000302
PCB-138 380.900 27,168.7 0.190181
PCB-153 382.200 27,265.9 0.190861
PCB-156 13.100 934.4 0.006541
PCB-169 0.400 28.1 0.000197
PCB-180 377.900 26,957.1 0.188700
aChemical concentration in the highest dose of the mixture
administered.Control group means ranged from 41.7 to
55.6 µg/dL, with an average coefﬁcient of vari-
ation of 15.3. All data values were standardized
to percentage of control for each chemical
[(experimental value/control mean) × 100].
Statistical modeling. The definition of
additivity (i.e., zero interaction) used is given
by Berenbaum (1985) and can be related to
the isobologram for a combination of chemi-
cals (Loewe 1953; Loewe and Muischnek
1926) through the interaction index. That is,
in a combination of c (here, c = 18) chemicals,
let Ei represent the concentration or dose of
the ith component alone that yields a fixed
response (i.e., ED30), y0, and let xi represent
the concentration/dose of the ith component
in combination with the c agents that yields
the same response. According to this defini-
tion, if the substances interact in an additive
fashion, then
[1]
If the left side of Equation 1, termed the
interaction index, is < 1, then a greater-than-
additive interaction (e.g., synergism) can be
claimed at the combination of interest. If the
left side of Equation 1 is > 1, then a less-than-
additive interaction (e.g., antagonism) can be
claimed at the combination.
The 18 chemicals were combined accord-
ing to a speciﬁed mixing ratio (Table 2) and
evaluated experimentally. The mixing ratio was
selected based on the ratios found in breast
milk, ﬁsh, and other sources of human expo-
sure, as described above. The mixing ratio is
denoted in terms of the proportion, ai, of each
chemical in the mixture (Table 2) such that
[2]
The FSCR approach of Gennings et al.
(2004) allows for different threshold parame-
ters and range parameters for each chemical
and ﬁxed-ratio mixture. The empirical mixture
data were modeled (termed the empirical
model) using a nonlinear exponential model of
the form
[3]
i = 1, . . . ,19
where αi + γi = 100, x is the dose of the ith
chemical (i = 1, . . . ,18) or the mixture dose
for the mixture ray (i = 19), αi is an unknown
parameter deﬁned by the maximum effect for
the ith chemical or mixture, βi is an
unknown parameter deﬁned by the slope for
the ith chemical or mixture, and δi is an
unknown parameter deﬁned by the threshold
along the ith ray for single chemicals (in
terms of dose) or mixtures (in terms of total
dose of the mixture). Preliminary inspection of
the data provided evidence that the variance of
the observed response increased with the mean
[i.e., Var(Y)=   τµ for unknown dispersion para-
meter τ]. Unknown parameters were estimated
using the method of maximum quasi likelihood
(McCullagh and Nelder 1989). The model in
Equation 3 was used to estimate the ED30
(i.e., the dose associated with a 30% decrease
from control) for each single chemical. The
delta method (Agresti 2002) was used to esti-
mate large sample 95% conﬁdence intervals on
the ED30 estimates.
We estimated the mixture dose–response
curve (Figure 1, empirical model) using the
model in Equation 3 for the speciﬁed mixture.
The dose–response curve for the mixture
assuming additivity (Figure 1, additivity
model) was estimated using only the single-
chemical dose–response model parameters and
the single-chemical data (Equation 3), then
predicting along the mixture ray with the con-
straint of additivity given in Equation 1.
To determine whether there was a statisti-
cally signiﬁcant deviation from additivity, we
used a quasi-likelihood ratio test to compare
the empirical mixture model to the restricted
additivity model based on an F-distribution.
The restricted additivity model (Gennings
et al. 2004) included only the single-chemical
dose–response model parameters but used both
the single-chemical and mixture data. We used
this restricted model to predict the mean
responses for the mixture data using the con-
straint of additivity given in Equation 1. In
addition we compared the predicted responses
from the mixture data under the hypothesis of
additivity (following the methods in Gennings
et al. 2002) to the observed sample means
using an F-test (df = 6, 1,305).
Results
We noted no visible signs of toxicity after the
short-term PHAH treatments. There were no
treatment-related effects on body weight gain.
Summary statistics for the single-chemical curve
ﬁts, including ED30 estimates and 95% conﬁ-
dence limits, are shown in Table 3. Summary
statistics for the individual chemical dose
groups can be found in Supplemental Data
Table 1 (http://ehp.niehs.nih.gov/docs/2005/
8195/supplemental.pdf).
Data modeling with the FSCR method
provided maximum effect parameters (asymp-
totes) and dose threshold parameters for 
each chemical and for the mixture. Note that
the dose–response model for OCDF was
reduced to background (100%) because the
slope parameter (β) was not significant (p =
0.84) and the maximum effect parameter was
not different from 100%. The estimates for the
maximum effect parameters (α) for the single
chemicals clustered into three groups, with
maximums at 14, 31, and 50% of control
µ
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Figure 1. Predicted effects on serum total T4 from the single-chemical data in an additivity model and
empirical effects of the PHAH mixture. Results demonstrate a significant deviation from additivity at the
three highest mixture doses. The effects of the lower mixture doses were not signiﬁcantly different than
that predicted by additivity. The inset illustrates the same data plotted as log-dose.
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)(Table 4). The data were also modeled with a
single-chemical-required (SCR) approach that
requires similar asymptotes (Casey et al. 2004).
This model proved to be inadequate with
signiﬁcant lack of ﬁt because of clearly different
asymptotes (p < 0.0001). The FSCR model
proved more appropriate as it allowed for three
different asymptotic levels, dose thresholds,
and no overall lack of ﬁt (p > 0.05).
Table 5 presents summary statistics for the
mixture data. The data reveal a mixture-
dose–dependent decrease in T4 concentrations
that produced a maximal decrease of approxi-
mately 50%. The experimental mixture data
and the fits of the empirical and additivity
models to the mixture data are shown in
Figure 1. Comparison of the dose–response
curve for the mixture under the hypothesis of
additivity (Figure 1, dashed line) to the ﬁt to
the empirical data (Figure 1, solid line) illustrate
the dose-dependent nature of the nonadditive
effects of the mixture (Figure 1). A quasi-likeli-
hood ratio test rejected the hypothesis of addi-
tivity (p < 0.001). Table 6 lists the results of an
overall (6 df) test of additivity where the null
hypothesis is that the true mean is equivalent to
the predicted mean from the FSCR model.
From this test, there is statistically signiﬁcant
evidence of departure from additivity (p <
0.001). Associated with this test are the six
comparisons at each mixture-dose group
(Table 6). The T4 mean for the mixtures at the
three highest mixture-dose groups (667, 1,335,
and 2,002 µg/kg/day) were each signiﬁcantly
different from that predicted under additivity.
Because the sample means are below that pre-
dicted under additivity, there is evidence of an
interaction (greater than additivity) at these
dose groups. The difference between the addi-
tivity model and empirical data (Figure 1) at
the three highest mixture doses (i.e., area of
maximal difference) was approximately 15% in
terms of T4 concentration or 2.5-fold on a
microgram per kilogram per day dose basis.
There was no evidence for signiﬁcant departure
from additivity at the three lowest doses of the
mixture (Table 6).
Discussion
The present study tested the hypothesis that a
mixture of TDCs affect T4 concentrations in a
dose-additive manner. We designed the mix-
ture so that highest mixture-dose levels of the
individual chemicals were at or below their no
observed effect levels. The FSCR additivity
model analyses demonstrate cumulative effects
of low doses of the mixture and synergistic
cumulative effects of the highest dosages of the
mixture. These data advocate consideration of
cumulative risk approaches when assessing the
risk of exposures to chemical mixtures that
contain TDCs.
The single-chemical and mixture data were
modeled successfully using the FSCR model.
Results demonstrate a very wide range of effec-
tive doses of PHAHs that decrease TH concen-
trations. These ﬁndings conﬁrm previous work
demonstrating that short-term exposure to
TCDD (Craft et al. 2002), and some individ-
ual PCB congeners for example, PCB con-
geners 47, 95, 101, and 153 (Craft et al. 2002;
Khan et al. 2002; Saeed and Hansen 1997)
cause hypothyroxinemia in the rat. Our present
work expands these findings by providing
dose–response data and relative potencies for
2 dioxins, 4 furans, and 12 PCB congeners.
OCDF was not effective at the doses used in
this animal dose model. This was expected
because of the limited absorption of this fully
chlorinated dibenzofuran (Birnbaum and
Couture 1988; DeVito et al. 1998). In addition
the ED30 estimates provide a basis for establish-
ing relative potency values for these chemicals.
Analyses of the mixtures data demon-
strated a dose-dependent synergy. The additiv-
ity model underestimated the actual toxic
effect of the mixture at the three highest doses
tested (Figure 1). Effects of the three lowest
doses of the mixture were not signiﬁcantly dif-
ferent than that predicted by the additivity
model. These conclusions are based on the use
of the FSCR method (Gennings et al. 2004).
These data were also analyzed using an SCR
method (Gennings et al. 2002). Although the
SCR model provided signiﬁcant evidence of a
greater-than-additive effect (data not shown),
this model was not appropriate for use with
these data because of signiﬁcant lack of ﬁt to
the data. The SCR model assumes a similar
asymptote for all single chemicals and the
mixture, a condition not satisfied in the
present data set. Use of the FSCR model
allowed for multiple asymptotic levels and
dose thresholds and resulted in a model with
no overall lack of ﬁt.
Three conclusions are apparent from
these data. The first is that exposure to the
Crofton et al.
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Table 5. Effects of PHAH mixture on serum T4 con-
centrations.
Mixture
dose Test solution T4 mean Sample
(µg/kg/day) (% stock) (% control ± SD) size
0 — 100.0 ± 11.8 12
20.0 0.33 106.8 ± 22.7 12
66.7 1.1 98.5 ± 21.7 12
200.3 3.3 94.6 ± 22.9 12
667.5 11 73.7 ± 14.6 12
1,335.1 22 62.9 ± 10.8 12
2,002.6 33 52.2 ± 15.1 12
Table 6. Test results for the hypothesis that mean T4
values for the mixture dose are equal to those pre-
dicted under the additivity model.
Mixture dose
Statistical test (µg/kg/day) Statistic p-Value
Overall F-test — 3.43 0.002
(df 6, 1,305)
Individual F-tests 20.0 1.65 0.200
(df 1, 1,305) 66.7 0.03 0.862
200.3 0.21 0.647
667.5 8.76 0.003*
1,335.1 7.91 0.005*
2,002.6 10.10 0.002*
*Dose groups where the mean T4 response is signiﬁcantly
different (p > 0.05) from that predicted under additivity.
Table 3. Summary statistics for individual chemicals,
and the ED30 and 95% conﬁdence intervals for each
chemical.
95%
ED30 Conﬁdence α Asymptote
Chemical (µg/kg/day) interval estimatea
TCDD 0.15 (0.08, 0.22) 50
PCDD 1.51 (1.10, 1.92) 31
TCDF 4.65 (1.90, 7.40) 50
1-PCDF 15.6 (10.17, 21.01) 50
4-PCDF 27.5 (17.05, 38.01) 50
OCDF — — —
PCB-28 76,103.0 (50,142, 102,064) 50
PCB-52 33,025.0 (20,958, 45,092) 50
PCB-77 852.0 (655, 1,049) 31
PCB-101 4,833.0 (3,819, 5,847) 31
PCB-105 1,031.0 (861, 1,200) 14
PCB-118 1,289.0 (1,103, 1,475) 14
PCB-126 1.33 (0.77, 1.88) 50
PCB-138 8,001.0 (6,692, 9,310) 14
PCB-153 12,696.0 (10,659, 14,732) 14
PCB-156 760.0 (629, 891) 14
PCB-169 227.0 (167, 286) 31
PCB-180 30,541.0 (23,122, 37,960) 31
aPercentage of control (e.g., α = 14 represents an 86%
decrease in T4 concentration relative to the control mean).
Table 4. Parameter estimates from the FSCR model. 
Parameter Estimate SE p-Value
α1,2,6,12,13,16,17 50.26 1.45 < 0.001
α3,10,11,14,15 30.74 1.95 < 0.001
α4,5,7,8,9 14.33 1.03 < 0.001
αmix 42.29 14.78 0.004
β1 (1-PCDF) –0.0608 0.0164 < 0.001
β2 (4-PCDF) –0.0378 0.0142 0.008
β3 (PCB-101) –0.000119 0.000020 < 0.001
β4 (PCB-105) –0.000833 0.000171 < 0.001
β5 (PCB-118) –0.000696 0.000109 < 0.001
β6 (PCB-126) –0.719000 0.225 0.001
β7 (PCB-138) –0.000054 0.000006 < 0.001
β8 (PCB-153) –0.000034 0.000003 < 0.001
β9 (PCB-156) –0.000567 0.000061 < 0.001
β10 (PCB-169) –0.002616 0.000549 < 0.001
β11 (PCB-180) –0.000021 0.000005 < 0.001
β12 (PCB-28) –0.000012 0.000003 < 0.001
β13 (PCB-52) –0.000028 0.000006 < 0.001
β14 (PCB-77) –0.000666 0.000102 < 0.001
β15 (PCDD) –0.374900 0.0639 < 0.001
β16 (TCDD) –6.505000 2.414 0.007
β17 (TCDF) –0.331000 0.274 0.228
θmix –0.000872 0.000467 0.062
δ1 0.389 1.500 0.795
δ2 3.094 3.927 0.431
δ3 76.410 398.449 0.848
δ4 513.1 147.9 0.001
δ5 669.5 147.5 < 0.001
δ6 0.043 0.130 0.742
δ10 9.812 25.104 0.696
δ11 3,227.3 5,581.7 0.563
δ16 0.004 0.020 0.855
δ17 1.859 0.977 0.057
δmix 49.5 74.3 0.50618 chemical mixture results in dose-dependent
greater-than-additive effects on T4 concentra-
tions at the highest mixture doses. This con-
clusion is supported by the FSCR analysis.
The second conclusion is that although the
greater-than-additive effects are statistically
signiﬁcant, the magnitude of underestimation
of the experimental data (Figure 1) by the
additivity model (Figure 1) is not large. On a
dose basis, the underestimation is about
2.5-fold for the three highest doses of the mix-
ture (Figure 1). This suggests that, even in the
high mixture-dose region, the effects of this
mixture are predicted by additivity with a fair
degree of accuracy. The third conclusion is
that departure from additivity was not
detected in the low-dose region. Although this
suggests that dose additivity predicts effects on
T4 at low exposures, it is tempered by a pre-
sumed low statistical power to detect differ-
ences in this area of the dose response.
A signiﬁcant ﬁnding in the present experi-
ment is that the mixture actually caused
decreases in T4 concentrations. This occurred
even though the individual chemical concen-
trations in the mixture were below effective
doses. For example, at the second highest mix-
ture dose there was a 38% decrease in T4. The
individual dose of PCB-153 at this mixture
dose was approximately 254 µg/kg/day. The
lowest effective dose of PCB-153 administered
alone is much greater than 2,000 µg/kg/day.
This relationship was similar for all the chemi-
cals in the mixture with one exception,
PCB-126. The dose of PCB-126 in the high-
est dose of the mixture caused about a 16%
decrease in T4. These data clearly demonstrate
the principle that simple mathematical addi-
tion of effects (i.e., effect addition) of individ-
ual chemicals will not predict the effects of
these TDCs in a mixture.
The biologic reasons for the greater-than-
additive effect of this mixture are currently
unknown. Risk assessment approaches to
additivity assume, where data are lacking
otherwise, that chemicals with similar modes
of action act in a dose-additive fashion (U.S.
EPA 1986, 2000). Although all the chemicals
used here decrease circulating T4 concentra-
tions, they may do so via a number of different
mechanisms. One postulated mechanism for
the reduction in T4 concentrations is the up-
regulation of hepatic UGT isoforms that glu-
curonidate T4, leading to biliary elimination
(Capen 1997; DeVito et al. 1999; Hill et al.
1998; McClain et al. 1989). Evidence suggests
that UGT1A1 and UGT1A6 are responsible
for T4 glucuronidation in the rat (Vansell and
Klaassen 2002; Visser et al. 1993). These UGT
isoforms are induced by aryl hydrocarbon
receptor (AhR), constitutive androstane recep-
tor (CAR), and pregnane-X receptor (PXR)
agonists. The dioxins, furans, and coplanar
PCBs (e.g., PCB-77, PCB-126) all activate
AhR (Wilson and Safe 1998), whereas the
more non-coplanar PCBs (e.g., PCB-52,
PCB-138, PCB-153) act via CAR/PXR path-
ways (Connor et al. 1995; Tabb et al. 2004).
Some of the chemicals tested (e.g., PCB-105,
PCB-118) are agonists for AhR, PXR, and
CAR. Activation of these UGTs through the
different nuclear receptors may play a role in
the synergistic effects. Differential regulation of
microsomal enzymes that glucuronidate T4
versus T3 (triiodothyronine) may also be
responsible (Hood and Klaassen 2000a). There
are a number of other postulated mechanisms
for altering circulating and tissue levels of THs.
Hydroxylated metabolites of PCBs displace T4
from transthyretin, a major serum transport
protein in rats (Brouwer et al. 1998). This
mechanism has been hypothesized to decrease
bound T4, resulting in greater uptake, catabo-
lism, and elimination of T4 (Van den Berg
et al. 1991). PCBs also alter deiodinases and
therefore iodination of THs (Hood and
Klaassen 2000b; Morse et al. 1993). There is
some evidence that PCBs increase uptake of T4
into the liver (Martin 2002), possibly by alter-
ing thyroid transporters (Guo et al. 2002). In
addition, Khan and Hansen (2003) and col-
leagues have demonstrated decreased pituitary
sensitivity to thyroid-stimulating hormone by
two PCB congeners. Therefore, the synergistic
effect may be the result of activation of multi-
ple pathways by the mixture, with the meas-
ured effect, T4, a common downstream end
point for these pathways.
The curve fits to the individual chemical
data revealed three levels of maximum efﬁcacy
(Table 4). Because of the limited number of
chemicals, it is difficult to quantitatively
describe the structure–activity relationship for
maximal T4 decreases. In addition the dose–
response determinations were not designed to
allow prediction of the asymptotic efﬁcacy but
instead aimed to characterize the low end of the
dose–response functions. In some cases the
maximal efﬁcacy was driven by the highest dose
tested, which did not demonstrate a clear maxi-
mal effect (e.g., PCB-28, PCB-52, PCB-169).
The data do support, with a number of excep-
tions, a rough separation of chemicals into the
more dioxin-like chemicals at the 50% point,
and mono- and di-ortho substituted chemicals
having an asymptote at 14%. A likely explana-
tion for the different efficacies is that the
PHAHs act through a variety a mechanisms, as
discussed above, and the interaction of these
mechanisms differentially affects T4 levels.
The significance of these findings for
environmental exposures is tempered by some
uncertainty. In our present study we used a
weanling animal model with a short (i.e.,
4-day) exposure duration. Short exposure
durations, coupled with differences in half-
lives of the chemicals in the mixture that vary
from a few weeks to many months (Van den
Berg et al. 1994), yield potential pharmacoki-
netic differences that may confound extrapo-
lation of these results. Pharmacokinetic
differences between short-term and steady-
state exposures may also include differences in
saturation of induction and metabolite gener-
ation. Thus, extrapolation of our present
ﬁndings to chronic exposures should be mod-
erated by these uncertainties.
Extrapolation of our present work in rats to
humans is tempered by the uncertainty in how
the mode(s) of action of the TDCs may differ
between species. Current hypotheses on the
mechanisms by which PHAHs decrease T4
include up-regulation of hepatic UGTs and sul-
fotransferases, direct effects on the thyroid
gland, and displacement of T4 from serum
transport proteins (Brouwer et al. 1998). Cross-
species extrapolation of these mechanisms is dif-
ficult (Crofton 2004). In addition one must
consider the degree of TH disruption that will
lead to adverse outcomes. Small decreases
(~ 25%) in maternal T4 during the early fetal
period will lead to adverse neurofunctional out-
comes (i.e., IQ scores) in humans (Haddow
et al. 2002; Morreale de Escobar et al. 2000).
Limited data in animals suggest that T4
decreases need to exceed 50% before adverse
outcomes can be detected (Crofton 2004).
A limited number of studies have examined
the effects of complex mixtures of endocrine-
disrupting chemicals (EDCs) (Desaulniers et al.
2003; Tinwell and Ashby 2004; Wade et al.
2002). Desaulniers et al. (2003) examined the
effects of a mixture of 16 coplanar PCBs,
PCDDs, and PCDFs on T4 concentrations in
neonatal rats. Decreases in T4 were associated
with dioxin equivalents using the toxic equiva-
lency factor methodology (Desaulniers et al.
2003; Van den Berg et al. 1998). Consistent
with our present ﬁndings, Wade et al. (2002)
found that effects on thyroid histopathology
and hormones were underpredicted based on
additivity of published health advisories (e.g.,
RfDs and ADIs). Evaluation of different mod-
els for determining the effects of a mixture of
seven EDCs on uterotrophic responses led to a
conclusion that the most expedient method is
to bioassay the mixture rather than test individ-
ual chemicals (LeBlanc and Olmstead 2004;
Tinwell and Ashby 2004). These studies lack,
either by study design or statistical approach,
the ability to test for additivity. The present
work expands the previous work by applying a
rigorous statistical analysis to test for additivity.
Conclusions
The present work demonstrates that the cumu-
lative effect of a mixture of TDCs is predicted
by additivity at low doses and synergy at high
doses. These data suggest that low doses of het-
erogeneous TDCs that alter thyroid homeosta-
sis should be considered together when
calculating the risk of exposures to mixtures.
Cumulative risk of thyroid disruptors
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Future work should endeavor to expand these
conclusions to low-dose chronic exposures and
broaden testing of mixtures to include chemi-
cals from diverse classes of thyroid disruptors
such as TH synthesis inhibitors.
REFERENCES
Agresti A. 2002. Categorical Data Analysis. 2nd ed. New
York:John Wiley & Sons.
Berenbaum MC. 1985. The expected effect of a combination of
agents: the general solution. J Theor Biol 114(3):413–431.
Birnbaum LS, Couture LA. 1988. Disposition of octa-
chlorodibenzo-p-dioxin (OCDD) in male rats. Toxicol Appl
Pharmacol 93(1):22–30.
Brouwer A, Morse DC, Lans MC, Schuur AG, Murk AJ, Klasson-
Wehler E, et al. 1998. Interactions of persistent environmen-
tal organohalogens with the thyroid hormone system:
mechanisms and possible consequences for animal and
human health. Toxicol Ind Health 14(1–2):59–84.
Capen C. 1998. Correlation of mechanistic data and histopathol-
ogy in the evaluation of selected toxic endpoints of the
endocrine system. Toxicol Lett 102–103:405–409.
Capen CC. 1997. Mechanistic data and risk assessment of
selected toxic end points of the thyroid gland. Toxicol Pathol
25(1):39–48.
Casey M, Gennings C, Carter JH Jr, Moser VC, Simmons JE. 2004.
Detecting interaction(s) and assessing the impact of compo-
nent subsets in a chemical mixture using ﬁxed-ratio mixture
ray designs. J Agric Biol Environ Stat 9(3):339–361.
Connor K, Safe S, Jefcoate CR, Larsen M. 1995. Structure-depen-
dent induction of CYP2B by polychlorinated biphenyl con-
geners in female Sprague-Dawley rats. Biochem Pharmacol
50(11):1913–1920.
Craft ES, DeVito MJ, Crofton KM. 2002. Comparative responsive-
ness of hypothyroxinemia and hepatic enzyme induction in
Long-Evans rats versus C57BL/6J mice exposed to TCDD-
like and phenobarbital-like polychlorinated biphenyl con-
geners. Toxicol Sci 68(2):372–380.
Crofton KM. 2004. Developmental disruption of thyroid hormone:
correlations with hearing dysfunction in rats. Risk Anal
24(6):1665–1671.
Daston GP, Cook JC, Kavlock RJ. 2003. Uncertainties for
endocrine disrupters: our view on progress. Toxicol Sci
74(2):245–252.
Desaulniers D, Leingartner K, Musicki B, Yagminas A, Xiao GH,
Cole J, et al. 2003. Effects of postnatal exposure to mixtures
of non-ortho-PCBs, PCDDs, and PCDFs in prepubertal female
rats. Toxicol Sci 75(2):468–480.
DeVito M, Biegel L, Brouwer A, Brown S, Brucker-Davis F, Cheek
AO, et al. 1999. Screening methods for thyroid hormone dis-
ruptors. Environ Health Perspect 107:407–415.
DeVito MJ, Birnbaum LS, Farland WH, Gasiewicz TA. 1995.
Comparisons of estimated human body burdens of dioxinlike
chemicals and TCDD body burdens in experimentally
exposed animals. Environ Health Perspect 103:820–831.
DeVito MJ, Ross DG, Dupuy AE Jr, Ferrario J, McDaniel D,
Birnbaum LS. 1998. Dose-response relationships for disposi-
tion and hepatic sequestration of polyhalogenated dibenzo-
p-dioxins, dibenzofurans, and biphenyls following
subchronic treatment in mice. Toxicol Sci 46(2):223–234.
Feron VJ, Groten JP. 2002. Toxicological evaluation of chemical
mixtures. Food Chem Toxicol 40(6):825–839.
Gennings C, Carter WH Jr, Campain JA, Bae D, Yang RSH. 2002.
Statitical analysis of interactive cytotoxicity in human epi-
dermal keratinocytes following exposure to a mixture of four
metals. J Agric Biol Environ Sci 7(1):58–73.
Gennings C, Carter WH Jr, Carney EW, Charles GD, Gollapudi
BB, Carchman RA. 2004. A novel ﬂexible approach for eval-
uating fixed ratio mixtures of full and partial agonists.
Toxicol Sci 80(1):134–150.
Giesy JP, Verbrugge DA, Othout RA, Bowerman WW, Mora MA,
Jones PD, et al. 1994. Contaminants in fishes from Great
Lakes-influenced sections and above dams of three
Michigan rivers. I: Concentrations of organo chlorine insec-
ticides, polychlorinated biphenyls, dioxin equivalents, and
mercury. Arch Environ Contam Toxicol 27(2):202–212.
Guo GL, Choudhuri S, Klaassen CD. 2002. Induction proﬁle of rat
organic anion transporting polypeptide 2 (oatp2) by proto-
typical drug-metabolizing enzyme inducers that activate
gene expression through ligand-activated transcription fac-
tor pathways. J Pharmacol Exp Ther 300(1):206–212.
Haddow JE, Palomaki GE, Williams J. 2002. Thyroid-stimulating-
hormone concentrations and risk of hypothyroidism. Lancet
360(9350):2081–2082.
Hill RN, Crisp TM, Hurley PM, Rosenthal SL, Singh DV. 1998. Risk
assessment of thyroid follicular cell tumors. Environ Health
Perspect 106:447–457.
Hood A, Klaassen CD. 2000a. Differential effects of microsomal
enzyme inducers on in vitro thyroxine (T(4)) and triiodothyro-
nine (T(3)) glucuronidation. Toxicol Sci 55(1):78–84.
Hood A, Klaassen CD. 2000b. Effects of microsomal enzyme
inducers on outer-ring deiodinase activity toward thyroid
hormones in various rat tissues. Toxicol Appl Pharmacol
163(3):240–248.
Hurley PM. 1998. Mode of carcinogenic action of pesticides
inducing thyroid follicular cell tumors in rodents. Environ
Health Perspect 106:437–445.
International Programme on Chemical Saftety. 2002. Global
Assessment of the State-of-the-Science of Endocrine
Disruptors. WHO/PCS/EDC/02.2 (Damstra T, Barlow S,
Bergman A, Kavlock R, Van Der Kraak G, eds). Geneva:
World Health Organization.
Khan MA, Hansen LG. 2003. Ortho-substituted polychlorinated
biphenyl (PCB) congeners (95 or 101) decrease pituitary
response to thyrotropin releasing hormone. Toxicol Lett
144(2):173–182.
Khan MA, Lichtensteiger CA, Faroon O, Mumtaz M, Schaeffer DJ,
Hansen LG. 2002. The hypothalamo-pituitary-thyroid (HPT)
axis: a target of nonpersistent ortho-substituted PCB con-
geners. Toxicol Sci 65(1):52–61.
Larsen BR, Turrio-Baldassarri L, Nilsson T, Iacovella N,
Di Domenico A, Montagna M, et al. 1994. Toxic PCB con-
geners and organochlorine pesticides in Italian human
milk. Ecotoxicol Environ Saf 28(1):1–13.
LeBlanc GA, Olmstead AW. 2004. Evaluating the toxicity of chemi-
cal mixtures [Letter]. Environ Health Perspect 112:A729–A730.
Liem AK, Furst P, Rappe C. 2000. Exposure of populations to
dioxins and related compounds. Food Addit Contam
17(4):241–259.
Loewe S. 1953. The problem of synergism and antagonism of
combined drugs. Arzneimittelforschung 3(6):285–290.
Loewe S, Muischnek H. 1926. Effect of combinations: mathemati-
cal basis of problem. Naunyn Schmiedebergs Arch Exp
Pathol Pharmakol 114:313–326.
Longnecker MP, Wolff MS, Gladen BC, Brock JW, Grandjean P,
Jacobson JL, et al. 2003. Comparison of polychlorinated
biphenyl levels across studies of human neurodevelopment.
Environ Health Perspect 111:65–70.
Lorber M. 2002. A pharmacokinetic model for estimating expo-
sure of Americans to dioxin-like compounds in the past, pre-
sent, and future. Sci Total Environ 288(1–2):81–95.
Martin LA. 2002. Differential effects of polychlorinated biphenyl
(PCB) mixtures and congeners on the disposition of thyrox-
ine (T4) in rats [PhD Dissertation]. Piscataway, NJ:Rutgers
University and Robert Wood Johnson Medical School.
McClain RM. 1995. Mechanistic considerations for the relevance
of animal data on thyroid neoplasia to human risk assess-
ment. Mutat Res 333(1–2):131–142.
McClain RM, Levin AA, Posch R, Downing JC. 1989. The effect of
phenobarbital on the metabolism and excretion of thyroxine
in rats. Toxicol Appl Pharmacol 99(2):216–228.
McCullagh P, Nelder JA. 1989. Generalized Linear Models. 2nd
ed. London:Chapman & Hall.
Morreale de Escobar G, Obregon MJ, Escobar del Rey F. 2000. Is
neuropsychological development related to maternal
hypothyroidism or to maternal hypothyroxinemia? J Clin
Endocrinol Metab 85(11):3975–3987.
Morse DC, Groen D, Veerman M, van Amerongen CJ, Koeter HB,
Smits van Prooije AE, et al. 1993. Interference of polychlori-
nated biphenyls in hepatic and brain thyroid hormone
metabolism in fetal and neonatal rats. Toxicol Appl
Pharmacol 122(1):27–33.
Oppenheimer JH, Bernstein G, Surks MI. 1968. Increased thyrox-
ine turnover and thyroidal function after stimulation of
hepatocellular binding of thyroxine by phenobarbital. J Clin
Invest 47(6):1399–1406.
Patterson DG Jr, Todd GD, Turner WE, Maggio V, Alexander LR,
Needham LL. 1994. Levels of non-ortho-substituted (co-
planar), mono- and di-ortho-substituted polychlorinated
biphenyls, dibenzo-p-dioxins, and dibenzofurans in human
serum and adipose tissue. Environ Health Perspect 102
(suppl 1):195–204.
Saeed A, Hansen LG. 1997. Morphometric changes in the prepu-
bertal female rat thyroid gland following acute exposure to
2,2’,4,4’-tetrachlorobiphenyl and Aroclor 1242. J Toxicol
Environ Health 51(5):503–513.
Schecter A, Stanley J, Boggess K, Masuda Y, Mes J, Wolff M,
et al. 1994a. Polychlorinated biphenyl levels in the tissues of
exposed and nonexposed humans. Environ Health Perspect
102(suppl 1):149–158.
Schecter A, Startin J, Wright C, Kelly M, Papke O, Lis A, et al.
1994b. Congener-specific levels of dioxins and dibenzo-
furans in U.S. food and estimated daily dioxin toxic equiva-
lent intake. Environ Health Perspect 102:962–966.
Tabb MM, Kholodovych V, Grun F, Zhou C, Welsh WJ, Blumberg
B. 2004. Highly chlorinated PCBs inhibit the human xenobi-
otic response mediated by the steroid and xenobiotic recep-
tor (SXR). Environ Health Perspect 112:163–169.
Teuschler L, Klaunig J, Carney E, Chambers J, Conolly R,
Gennings C, et al. 2002. Support of science-based decisions
concerning the evaluation of the toxicology of mixtures: a
new beginning. Regul Toxicol Pharmacol 36(1):34–39.
Tinwell H, Ashby J. 2004. Sensitivity of the immature rat
uterotrophic assay to mixtures of estrogens. Environ Health
Perspect 112:575–582.
U.S. EPA (U.S. Environmental Protection Agency). 1986.
Guidelines for the health risk assessment of chemical mix-
tures. Fed Reg 51:34014–34025.
U.S. EPA. 2000. Supplementary Guidance for Conducting Health
Risk Assessment of Chemical Mixtures. Washington, DC:U.S.
Environmental Protection Agency.
Van den Berg KJ, van Raaij JA, Bragt PC, Notten WR. 1991.
Interactions of halogenated industrial chemicals with
transthyretin and effects on thyroid hormone levels in vivo.
Arch Toxicol 65(1):15–19.
Van den Berg M, Birnbaum L, Bosveld AT, Brunstrom B, Cook P,
Feeley M, et al. 1998. Toxic equivalency factors (TEFs) for
PCBs, PCDDs, PCDFs for humans and wildlife. Environ
Health Perspect 106:775–792.
Van den Berg M, De Jongh J, Poiger H, Olson JR. 1994. The toxi-
cokinetics and metabolism of polychlorinated dibenzo-p-
dioxins (PCDDs) and dibenzofurans (PCDFs) and their
relevance for toxicity. Crit Rev Toxicol 24(1):1–74.
Vansell NR, Klaassen CD. 2002. Increase in rat liver UDP-
glucuronosyltransferase mRNA by microsomal enzyme
inducers that enhance thyroid hormone glucuronidation.
Drug Metab Dispos 30(3):240–246.
Visser TJ, Kaptein E, van Raaij JA, Joe CT, Ebner T, Burchell B.
1993. Multiple UDP-glucuronyltransferases for the glu-
curonidation of thyroid hormone with preference for 3,3’,5’-
triiodothyronine (reverse T3). FEBS Lett 315(1):65–68.
Wade MG, Parent S, Finnson KW, Foster W, Younglai E,
McMahon A, et al. 2002. Thyroid toxicity due to subchronic
exposure to a complex mixture of 16 organochlorines, lead,
and cadmium. Toxicol Sci 67(2):207–218.
Wilson CL, Safe S. 1998. Mechanisms of ligand-induced aryl
hydrocarbon receptor-mediated biochemical and toxic
responses. Toxicol Pathol 26(5):657–671.
Wolff J. 1998. Perchlorate and the thyroid gland. Pharmacol Rev
50(1):89–105.